Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. SXTC
stocks logo

SXTC

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Valuation Metrics

The current forward P/E ratio for China SXT Pharmaceuticals Inc (SXTC.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess China SXT Pharmaceuticals Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

SXTC News & Events

Events Timeline

(ET)
2025-03-17
08:33:45
China SXT Pharmaceuticals regains compliance with Nasdaq
select
2024-10-07 (ET)
2024-10-07
16:20:38
China SXT Pharmaceuticals receives noncompliance notification from Nasdaq
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.0
05-19Benzinga
Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

  • Novavax Vaccine Approval: Novavax, Inc. shares surged 16.6% to $7.84 in pre-market trading following the FDA's conditional approval of its COVID-19 vaccine for specific populations.

  • Market Movements: Several stocks experienced significant pre-market fluctuations, with Healthcare Triangle, Inc. rising 59.2%, while Affimed N.V. saw a decline of 35.5%.

[object Object]
Preview
2.0
05-06Benzinga
Why ThredUp Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

  • ThredUp Inc. Performance: ThredUp's shares surged 19.6% in pre-market trading after reporting a smaller-than-expected loss of 4 cents per share and exceeding sales expectations with $71.29 million, while also raising its FY25 sales forecast.

  • Market Movements: Several stocks experienced significant pre-market movements, including AIFU Inc. rising 76.4% and Cadiz Inc. dropping 37.4%, alongside notable performances from Marin Software and WeRide Inc. due to strategic partnerships and financial results.

[object Object]
Preview
9.5
04-23Benzinga
Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket

  • Vertiv Holdings Co Performance: Vertiv's shares surged 17% in pre-market trading after reporting first-quarter earnings of 64 cents per share and sales of $2.04 billion, both exceeding analyst expectations. The company also raised its full-year sales guidance.

  • Market Movements: Several stocks experienced significant pre-market movements, with AGM Group Holdings rising 135.3% and Sonoma Pharmaceuticals surging 99.6%, while Marin Software saw a decline of 28% following regulatory issues.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is China SXT Pharmaceuticals Inc (SXTC) stock price today?

The current price of SXTC is 1.43 USD — it has increased 0.7 % in the last trading day.

arrow icon

What is China SXT Pharmaceuticals Inc (SXTC)'s business?

China SXT Pharmaceuticals Inc is a holding company mainly engaged in the research, development, manufacture, marketing and sales of Chinese traditional medicine products (TCMP). The Company sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The Company sells its products under the brand Suxuantang.

arrow icon

What is the price predicton of SXTC Stock?

Wall Street analysts forecast SXTC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SXTC is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is China SXT Pharmaceuticals Inc (SXTC)'s revenue for the last quarter?

China SXT Pharmaceuticals Inc revenue for the last quarter amounts to NaN USD, decreased % YoY.

arrow icon

What is China SXT Pharmaceuticals Inc (SXTC)'s earnings per share (EPS) for the last quarter?

China SXT Pharmaceuticals Inc. EPS for the last quarter amounts to USD, decreased % YoY.

arrow icon

What changes have occurred in the market's expectations for China SXT Pharmaceuticals Inc (SXTC)'s fundamentals?

The market is revising No Change the revenue expectations for SXTC for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -11.18%.
arrow icon

How many employees does China SXT Pharmaceuticals Inc (SXTC). have?

China SXT Pharmaceuticals Inc (SXTC) has 75 emplpoyees as of December 05 2025.

arrow icon

What is China SXT Pharmaceuticals Inc (SXTC) market cap?

Today SXTC has the market capitalization of 165.92M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free